TPP proposals would cost $215 million more for medicines per year
A study by health experts published in late December 2014 examines the potential costs for Australia of a proposal in the leaked intellectual property chapter of the Trans-Pacific Trade deal which would delay the availability of cheaper generic medicines and would cost taxpayers over $205 million in one year,